SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-017410
Filing Date
2022-08-15
Accepted
2022-08-15 17:03:09
Documents
13
Period of Report
2022-08-10
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pali-20220810.htm   iXBRL 8-K 55661
2 EX-3.1 pali-ex3_1.htm EX-3.1 295343
  Complete submission text file 0000950170-22-017410.txt   514519

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pali-20220810_lab.xml EX-101.LAB 14565
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pali-20220810.xsd EX-101.SCH 2478
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pali-20220810_pre.xml EX-101.PRE 10683
7 EXTRACTED XBRL INSTANCE DOCUMENT pali-20220810_htm.xml XML 5091
Mailing Address 5800 ARMADA DRIVE, SUITE 210 CARLSBAD CA 92008
Business Address 5800 ARMADA DRIVE, SUITE 210 CARLSBAD CA 92008 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33672 | Film No.: 221166523
SIC: 2836 Biological Products, (No Diagnostic Substances)